Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Annals of Surgical Oncology
Published in: Annals of Surgical Oncology 8/2016

01-08-2016 | Gastrointestinal Oncology

Is Extended Lymphadenectomy Needed for Elderly Patients With Gastric Adenocarcinoma?

Authors: Guillaume Passot, MD, PhD, Delphine Vaudoyer, MD, Mathieu Messager, MD, PhD, Kristoffer W. Brudvik, MD, PhD, Bradford J. Kim, MD, MHS, Christophe Mariette, MD, PhD, Olivier Glehen, MD, PhD

Published in: Annals of Surgical Oncology | Issue 8/2016

Login to get access

Abstract

Background

Extensive surgery is associated with greater mortality for elderly patients. For gastric adenocarcinoma (GA), it is unclear whether the benefit of an extended lymphadenectomy in this population outweighs the associated risks. This study aimed to determine the impact of lymphadenectomy on postoperative outcomes and survival for the elderly.

Objective

To determine the impact of lymphadenectomy on postoperative outcomes and survival for elderly.

Methods

From a cohort of 19 centers, patients who underwent resection of GA with curative intent between 1997 and 2010 were included in this study. Lymphadenectomy was defined according to the total number of lymph nodes in the surgical specimen (limited, <15; intermediate, 15–25; extended, >25). Postoperative outcomes and survival were compared between elderly (≥75 years) and younger patients and regarding the extent of lymphadenectomy for the elderly.

Results

Of 1348 patients, 386 were elderly. The elderly presented with a higher American Society of Anesthesiologist (ASA) score (ASA 3–4: 45 vs. 16.5 %; p < 0.001) as well as greater postoperative morbidity (45 vs. 37 %; p = 0.009) and mortality (8 vs. 2.5 %; p < 0.001) despite less aggressive treatment including less neoadjuvant chemotherapy (5 vs. 20 %; p < 0.001) and adjuvant chemotherapy (7 vs. 44 %; p < 0.001), fewer total gastrectomies (41.5 vs. 60 %; p < 0.001), and less extended lymphadenectomy (38 vs. 48.5 %; p < 0.001). Among the elderly patients, limited lymphadenectomy (n = 116), intermediate lymphadenectomy (n = 125), and extended lymphadenectomy (n = 145) were comparable with respect to tumor stage, perioperative treatment, morbidity, and mortality. For the elderly patients, overall survival (OS) was 30.8 months, and disease-specific survival (DSS) was 63.9 months. The extent of the lymphadenectomy did not have an impact on OS or DSS for the elderly patients.

Conclusion

The expected benefit in terms of long-term survival did not justify an extended lymphadenectomy for elderly patients.
Literature
1.
Kamangar F, Dores GM, Anderson WF. Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. J Clin Oncol. 2006;24:2137–50.CrossRefPubMed
2.
3.
Cunningham D, Allum WH, Stenning SP, et al. Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med. 2006;355:11–20.CrossRefPubMed
4.
Macdonald JS, Smalley SR, Benedetti J, et al. Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. N Engl J Med. 2001;345:725–30.CrossRefPubMed
5.
Sakuramoto S, Sasako M, Yamaguchi T, et al. Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine. N Engl J Med. 2007;357:1810–20.CrossRefPubMed
6.
Bonenkamp JJ, Songun I, Hermans J, et al. Randomised comparison of morbidity after D1 and D2 dissection for gastric cancer in 996 Dutch patients. Lancet. 1995;345:745–8.CrossRefPubMed
7.
Al-Refaie WB, Parsons HM, Henderson WG, et al. Major cancer surgery in the elderly: results from the American College of Surgeons National Surgical Quality Improvement Program. Ann Surg. 2010;251:311–8.CrossRefPubMed
8.
9.
Galizia G, Lieto E, De Vita F, et al. Modified versus standard D2 lymphadenectomy in total gastrectomy for nonjunctional gastric carcinoma with lymph node metastasis. Surgery. 2015;157:285–96.CrossRefPubMed
10.
Griffith JP, Sue-Ling HM, Martin I, et al. Preservation of the spleen improves survival after radical surgery for gastric cancer. Gut. 1995;36:684–90.CrossRefPubMedPubMedCentral
11.
Messager M, Lefevre JH, Pichot-Delahaye V, et al. The impact of perioperative chemotherapy on survival in patients with gastric signet ring cell adenocarcinoma: a multicenter comparative study. Ann Surg. 2011;254:684–93; discussion 693.
12.
Farrow SC, Fowkes FG, Lunn JN, et al. Epidemiology in anaesthesia: a method for predicting hospital mortality. Eur J Anaesthesiol. 1984;1:77–84.PubMed
13.
Ychou M, Boige V, Pignon JP, et al. Perioperative chemotherapy compared with surgery alone for resectable gastroesophageal adenocarcinoma: an FNCLCC and FFCD multicenter phase III trial. J Clin Oncol. 2011;29:1715–21.CrossRefPubMed
14.
Anderson O, Ni Z, Moller H, et al. Hospital volume and survival in oesophagectomy and gastrectomy for cancer. Eur J Cancer. 2011;47:2408–14.CrossRefPubMed
15.
Sobin LH, Wittekind C. International Union Against Cancer (UICC) TNM Classification of Malignant Tumors. 7th ed. Wiley-Black-Well, Oxford, 2009.
16.
Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240:205–13.CrossRefPubMedPubMedCentral
17.
Cuschieri A, Weeden S, Fielding J, et al. Patient survival after D1 and D2 resections for gastric cancer: long-term results of the MRC randomized surgical trial. Surgical Co-operative Group. Br J Cancer. 1999;79:1522–30.CrossRefPubMedPubMedCentral
18.
Hartgrink HH, van de Velde CJ, Putter H, et al. Extended lymph node dissection for gastric cancer: who may benefit? Final results of the randomized Dutch gastric cancer group trial. J Clin Oncol. 2004;22:2069–77.CrossRefPubMed
19.
Songun I, Putter H, Kranenbarg EM, et al. Surgical treatment of gastric cancer: 15-year follow-up results of the randomised nationwide Dutch D1D2 trial. Lancet Oncol. 2010;11:439–49.CrossRefPubMed
20.
Schwarz RE, Smith DD. Extended lymph node dissection for gastric cancer: who may benefit? Final results of the randomized Dutch gastric cancer group trial. J Clin Oncol. 2005;23:5404–5; author reply 5405.
21.
Eguchi T, Takahashi Y, Ikarashi M, et al. Is extended lymph node dissection necessary for gastric cancer in elderly patients? Eur J Surg. 2000;166:949–53.CrossRefPubMed
22.
Takeshita H, Ichikawa D, Komatsu S, et al. Surgical outcomes of gastrectomy for elderly patients with gastric cancer. World J Surg. 2013;37:2891–8.CrossRefPubMed
23.
Katai H, Sasako M, Sano T, et al. Gastric cancer surgery in the elderly without operative mortality. Surg Oncol. 2004;13:235–8.CrossRefPubMed
24.
Takama T, Okano K, Kondo A, et al. Predictors of postoperative complications in elderly and oldest old patients with gastric cancer. Gastric Cancer. 2014;18:653–61.CrossRefPubMed
25.
Takeuchi D, Koide N, Suzuki A, et al. Postoperative complications in elderly patients with gastric cancer. J Surg Res. 2015;198:317–26.CrossRefPubMed
26.
Wu CW, Lo SS, Shen KH, et al. Surgical mortality, survival, and quality of life after resection for gastric cancer in the elderly. World J Surg. 2000;24:465–72.CrossRefPubMed
27.
Otsuji E, Fujiyama J, Takagi T, et al. Results of total gastrectomy with extended lymphadenectomy for gastric cancer in elderly patients. J Surg Oncol. 2005;91:232–6.CrossRefPubMed
28.
Eguchi T, Fujii M, Takayama T. Mortality for gastric cancer in elderly patients. J Surg Oncol. 2003;84:132–6.CrossRefPubMed
29.
Katai H, Sasako M, Sano T, et al. The outcome of surgical treatment for gastric carcinoma in the elderly. Jpn J Clin Oncol. 1998;28:112–5.CrossRefPubMed
30.
Kunisaki C, Akiyama H, Nomura M, et al. Comparison of surgical outcomes of gastric cancer in elderly and middle-aged patients. Am J Surg. 2006;191:216–24.CrossRefPubMed
31.
Visnjevac O, Nader N. Is ASA classification a valid prognosticator in octogenarians? Probably not. J Anesth Clin Res. 2013;4:350
32.
Visnjevac O, Lee J, Pourafkari L, et al. Functional capacity as a significant independent predictor of postoperative mortality for octogenarian ASA-III patients. J Gerontol A Biol Sci Med Sci. 2014;69:1229–35.CrossRefPubMed
Metadata
Title
Is Extended Lymphadenectomy Needed for Elderly Patients With Gastric Adenocarcinoma?
Authors
Guillaume Passot, MD, PhD
Delphine Vaudoyer, MD
Mathieu Messager, MD, PhD
Kristoffer W. Brudvik, MD, PhD
Bradford J. Kim, MD, MHS
Christophe Mariette, MD, PhD
Olivier Glehen, MD, PhD
Publication date
01-08-2016
Publisher
Springer International Publishing
Published in
Annals of Surgical Oncology / Issue 8/2016
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-016-5260-x

Other articles of this Issue 8/2016

Annals of Surgical Oncology 8/2016 Go to the issue

Endocrine Tumors

Racial Disparities in Initial Presentation of Benign Thyroid Disease for Resection

Colorectal Cancer

Skeletal Muscle Changes After Elective Colorectal Cancer Resection: A Longitudinal Study

Thoracic Oncology

Hiatal Hernia After Open versus Minimally Invasive Esophagectomy: A Systematic Review and Meta-analysis

Breast Oncology

Intraductal Papilloma with Benign Pathology on Breast Core Biopsy: To Excise or Not?

Breast Oncology

Post-mastectomy Radiation: Should Subtype Factor into the Decision?

Bone and Soft Tissue Sarcomas

Worse Survival in Elderly Patients with Extremity Soft-Tissue Sarcoma